BKHAU — Black Hawk Acquisition Corp
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 2000775 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| May 2026 | 0 | — | -109,215 | 88,929 | 25,376,246 | 11,583 | 5,166,806 |
| Feb 2026 | 0 | — | -54,189 | 139,805 | 24,821,943 | 178,407 | 4,701,432 |
| Nov 2025 | 0 | — | -217,878 | -3,765 | 23,877,939 | 39,521 | 3,897,233 |
| May 2025 | 0 | — | -247,598 | 520,542 | 73,502,321 | 72,914 | 2,666,043 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-725,232
Investing CF
$-1,350,000
Financing CF
$2,043,201
CapEx
—
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
—
As of
2026-07-19
Balance + Analyst (yfinance extras)
Retained Earnings
$-5,108,417
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$2,835,748
Pretax Income TTM
$745,510
Interest Exp TTM
$43,830
Analysts
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Nov 2025 | 0 | -915,510 | 1,329,557 | 23,877,939 | 3,897,233 | 19,980,706 | -650,321 |
| Nov 2024 | 0 | -576,076 | 1,915,703 | 72,143,335 | 2,485,978 | 69,657,357 | -553,665 |
| Nov 2023 | — | — | — | 263,000 | 256,853 | 6,147 | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $224.15B | $414.61 | — |
| GILD | GILEAD SCIENCES, INC. | $187.15B | $150.93 | — |
| MRNA | Moderna, Inc. | $79.40B | $198.88 | — |
| ARGX | ARGENX SE | $59.67B | $959.49 | — |
| RVMD | Revolution Medicines, Inc. | $43.93B | $204.97 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.